Organogenesis Holdings (ORGO) Deferred Taxes (2023 - 2026)

Organogenesis Holdings' Deferred Taxes history runs 4 years deep, the most recent figure standing at -$15.4 million for Q1 2026.

• On a quarterly basis, Deferred Taxes fell 1114.14% year-over-year to -$15.4 million in Q1 2026; TTM through Mar 2026 was -$6.8 million, a 80.46% decrease from a year earlier, with the FY2025 full-year figure at $7.3 million, up 189.41% from the prior year.
• Deferred Taxes declined to -$15.4 million in Q1 2026 per ORGO's latest filing, from $13.5 million in the prior quarter.
• Across five years, Deferred Taxes topped out at $13.5 million in Q4 2025 and bottomed at -$15.4 million in Q1 2026.
• The 4-year median for Deferred Taxes is -$1.1 million (2025), against an average of -$1.3 million.
• Across the five-year window, Deferred Taxes sank 2453.85% in 2024 and soared 4496.73% in 2025, its largest moves.
• Year by year, Deferred Taxes stood at $13000.0 in 2023, then sank by 2453.85% to -$306000.0 in 2024, then surged by 4496.73% to $13.5 million in 2025, then sank by 214.25% to -$15.4 million in 2026.
• Per Business Quant, the three latest ORGO Deferred Taxes figures stand at -$15.4 million (Q1 2026), $13.5 million (Q4 2025), and -$3.8 million (Q3 2025).